[{"notes_id":"1_2945","category":"5","subcategory":"1","title":"Chickenpox exposure in at risk groups","body":"Whilst chickenpox is generally a mild condition in children with normal immune systems, serious systemic disease may occur in at-risk groups. It also poses special risks to pregnant women, particularly to the developing fetus. It is therefore important to know how to manage varicella exposure in these special groups.<br \/><br \/>Post-exposure prophylaxis criteria<br \/><ul><li>The following criteria should be met to determine who would benefit from active post-exposure prophylaxis:<ul><li>Significant exposure to chickenpox or herpes zoster<\/li><li>Exposure to limited, covered-up shingles may not warrant post-exposure prophylaxis<\/li><li>The infectious period for chickenpox is from 24 hours prior to rash onset to 5 days after rash first appears in immunocompetent individuals<\/li><li>For immunosuppressed individuals, the infectious period extends until all lesions have crusted over<\/li><\/ul><\/li><li>A clinical condition that increases the risk of severe varicella<ul><li>Immunosuppressed patients (including those on long-term steroids, methotrexate and other common <li>immunosuppressants)<\/li><li>Neonates (particularly those in specific high-risk categories)<\/li><li>Pregnant women<\/li><\/ul><\/li><li>No antibodies to the varicella virus<ul><li><span class=\"concept\" data-cid=\"12423\">Ideally all at-risk exposed patients should have urgent blood test for varicella antibodies (can be performed within 24 hours)<\/span><\/li><li>This should not delay post-exposure prophylaxis past 7 days after initial contact<\/li><li>For immunocompetent individuals: VZV IgG <100 mIU\/ml indicates susceptibility<\/li><li>For immunosuppressed patients: VZV IgG <150 mIU\/ml indicates need for treatment<\/li><\/ul><\/li><\/ul><br \/><b>Current treatment recommendations<\/b><br \/><br \/>Varicella-zoster immunoglobulin (VZIG) is no longer available in the UK as of September 2024. Oral antivirals are now the first-line treatment for post-exposure prophylaxis in all at-risk groups.<br \/><br \/>First-line treatment: <span class=\"concept\" data-cid=\"12424\">Oral antivirals<\/span><br \/><ul><li>Patients who fulfill the above criteria should be given oral aciclovir or valaciclovir:<ul><li>Timing: Start from day 7 to day 14 after the first day of exposure<\/li><li>Duration: 7-day course<\/li><li>Late presentation: Can be started up to day 14 after exposure if necessary<\/li><\/ul><\/li><\/ul><br \/>The management of chickenpox exposure in pregnancy is an important topic that is covered in more detail in a separate entry to the textbook.","notes_hash":"53ee8c3cadf8f9612161c4e94aef6d0e","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>Greenbook<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2040\" data-linkid=\"2040\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_2040\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">3<\/span><button type=\"button\" style=\"\" id=\"link_dislike_2040\" data-linkid=\"2040\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_2040\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.gov.uk\/government\/publications\/varicella-the-green-book-chapter-34\">Varicella<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"12423":{"concept_text":"At-risk patients who are exposed to varicella should have an urgent blood test for VZV IgG antibodies","concept_percentile":"48"},"12424":{"concept_text":"Oral antivirals should be used for at risk individuals exposed to varicella, starting on day 7 from the date of exposure","concept_percentile":"78"}},"category_name":"Infectious disease \/ Haematology \/ Immunology","subcategory_name":"Infectious disease","comment_count":7},"",[]]